| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.017 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |